Serum bactericidal activity and postantibiotic effect in serum of patients with urinary tract infection receiving high-dose amikacin
- PMID: 3116918
- PMCID: PMC174872
- DOI: 10.1128/AAC.31.7.1061
Serum bactericidal activity and postantibiotic effect in serum of patients with urinary tract infection receiving high-dose amikacin
Abstract
Ten patients received a 30-min infusion of amikacin (30 mg/kg) on day 1 and 15 mg/kg on day 2. Mean serum creatinine was 1.1 +/- 0.3 (standard deviation) mg/dl before and 1.0 +/- 0.3 mg/dl 3 days after the second infusion. Mean serum amikacin concentrations before, at the end of infusion, and 1, 6, 12, and 24 h after 30 and 15 mg/kg were 0, 157, 79, 31, 16, 5, 5, 85, 51, 19, 12, and 5 mg/liter, respectively. Five strains each of Staphylococcus aureus, Staphylococcus epidermidis susceptible and resistant to oxacillin, Streptococcus (Enterococcus) faecalis, corynebacterium sp. strain JK, Listeria monocytogenes, Mycobacterium fortuitum (three strains), Klebsiella pneumoniae, Serratia marcescens, Acinetobacter calcoaceticus, and Pseudomonas aeruginosa were tested. Serum bactericidal activities (SBAs) were greater than or equal to 1:8 in greater than or equal to 80% of the sera 1 and 6 h after 30 mg/kg and in greater than or equal to 60% of the sera 1 and 6 h after 15 mg/kg against Staphylococcus aureus and Staphylococcus epidermidis susceptible to oxacillin, A. calcoaceticus, and K. pneumoniae. L. monocytogenes, Serratia marcescens, and P. aeruginosa had lower SBAs. Very low or no activity was observed against oxacillin-resistant staphylococci and Streptococcus faecalis. The study of the killing rate in serum confirmed these results. Postantibiotic effect was studied by incubating a strain from each species in serum samples obtained 1 and 6 h after both regimens for 0.5, 1, or 2 h. The duration of postantibiotic effect depended on the duration of contact and the concentration of amikacin for the following organisms: oxacillin-susceptible staphylococci, L. monocytogenes, P. aeruginosa, A. calcoaceticus, K. pneumoniae, and Serratia marcescens. M. fortuitum was killed after 30 min of contact. No postantibiotic effect was observed with Streptococcus faecalis, Corynebacterium sp. strain JK, or oxacillin-resistant staphylococci. Amikacin at 30 mg/kg provided high levels and SBAs against susceptible pathogens. Prolonged postantibiotic effects were observed. No signs of nephrotoxicity occurred.
Similar articles
-
Bactericidal activity and killing rate of serum in volunteers receiving vancomycin or teicoplanin with and without amikacin given intravenously.J Antimicrob Chemother. 1987 May;19(5):623-35. doi: 10.1093/jac/19.5.623. J Antimicrob Chemother. 1987. PMID: 2956228 Clinical Trial.
-
Bactericidal activity and killing rate of serum from volunteers receiving pefloxacin alone or in combination with amikacin.Antimicrob Agents Chemother. 1986 Feb;29(2):230-4. doi: 10.1128/AAC.29.2.230. Antimicrob Agents Chemother. 1986. PMID: 3087276 Free PMC article.
-
Ex vivo study of serum bactericidal titers and killing rates of daptomycin (LY146032) combined or not combined with amikacin compared with those of vancomycin.Antimicrob Agents Chemother. 1989 Oct;33(10):1783-90. doi: 10.1128/AAC.33.10.1783. Antimicrob Agents Chemother. 1989. PMID: 2556079 Free PMC article. Clinical Trial.
-
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].Jpn J Antibiot. 1998 Feb;51(2):69-111. Jpn J Antibiot. 1998. PMID: 9575437 Japanese.
-
Human pathogenic bacteria, fungi, and viruses in Drosophila: disease modeling, lessons, and shortcomings.Virulence. 2014 Feb 15;5(2):253-69. doi: 10.4161/viru.27524. Epub 2014 Jan 7. Virulence. 2014. PMID: 24398387 Free PMC article. Review.
Cited by
-
Therapeutic drug monitoring of amikacin in septic patients.Crit Care. 2013 Jul 25;17(4):R165. doi: 10.1186/cc12844. Crit Care. 2013. PMID: 23886243 Free PMC article.
-
Adsorption of amikacin, a significant mechanism of elimination by hemofiltration.Antimicrob Agents Chemother. 2008 Mar;52(3):1009-13. doi: 10.1128/AAC.00858-07. Epub 2007 Dec 17. Antimicrob Agents Chemother. 2008. PMID: 18086842 Free PMC article.
-
Optimized antimicrobial dosing strategies: a survey of pediatric hospitals.Paediatr Drugs. 2014 Dec;16(6):523-9. doi: 10.1007/s40272-014-0093-1. Paediatr Drugs. 2014. PMID: 25315265
-
Systematic review of high-dose amikacin regimens for the treatment of Gram-negative infections based on EUCAST dosing recommendations.Eur J Hosp Pharm. 2023 Jul;30(4):189-195. doi: 10.1136/ejhpharm-2022-003421. Epub 2022 Nov 7. Eur J Hosp Pharm. 2023. PMID: 36344247 Free PMC article.
-
Postexposure factors influencing the duration of postantibiotic effect: significance of temperature, pH, cations, and oxygen tension.Antimicrob Agents Chemother. 1997 Aug;41(8):1693-6. doi: 10.1128/AAC.41.8.1693. Antimicrob Agents Chemother. 1997. PMID: 9257743 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical